Controlled Crystallization During Freeze-Drying - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Controlled Crystallization During Freeze-Drying
The authors discuss the preparation of lipophilic drug nanocrystals by controlled crystallization during freeze-drying.


Pharmaceutical Technology
Volume 35, Issue 8, pp. 58-62

Conclusion

By using in-line Raman spectroscopy, it was shown that during the freezing step of the CCDF process only the solvents crystallized. The solutes did not crystallize until the temperature in the freeze-dryer was increased. Furthermore, the three-way nozzle can be used to alter the small-batch process into a semicontinuous process that is suitable for large-scale production. Controlled crystallized dispersions prepared by the semicontinuous process results in even smaller nanocrystals due to a higher freezing rate. Therefore, the semicontinuous process is not only suitable for large-scale production, but can also result in a better product.

Hans de Waard* is postdoctoral researcher, Niels Grasmeijer is a doctoral student, Wouter L.J. Hinrichs is senior researcher, and Professor Henderik W. Frijlink is chairman, all at the Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands, tel. +31 50 363 2397, fax +31 50 363 2500,
. Professor Thomas De Beer is a professor in the Laboratory of Pharmaceutical Process Analytical Technology at the Department of Pharmaceutical Analysis, Ghent University.

*To whom all correspondence should be addressed.

Submitted: Feb. 11, 2011. Accepted: Apr. 27, 2011.

References

1. C.A. Lipinski et al., Adv. Drug Deliv. Rev. 46 (1–3), 3–26 (2001).

2. G.L. Amidon et al., Pharm. Res. 12 (3), 413–420 (1995).

3. W. Curatolo, Pharm. Sci. Tech. Today 1 (9), 387–393 (1998).

4. D. Hou et al., Biomaterials 24 (10), 1781–1785 (2003).

5. A.A. Noyes and W.R. Whitney, J. Am. Chem. Soc. 19 (12), 930–934 (1897).

6. C.M. Keck and R.H. Muller, Eur. J. Pharm. Biopharm. 62 (1), 3–16 (2006).

7. B.Y. Shekunov et al., Pharm. Res. 23 (1), 196-204 (2006).

8. H. de Waard, W.L.J. Hinrichs, and H.W. Frijlink, J. Control. Release 128 (2), 179–183 (2008).

9. D.J. van Drooge, W.L.J. Hinrichs, and H.W. Frijlink, J. Pharm. Sci. 93 (3), 713–725 (2004).

10. R.L. McCreery, Raman Spectroscopy for Chemical Analysis, (Wiley-Interscience, New York, 1st ed., 2000).

11. H. de Waard et al., Eur. J. Pharm. Sci. 38 (3), 224–229 (2009).

12. J. Hu et al., Pharm. Res. 19 (9), 1278-1284 (2002).

13. M.J. Pikal, "Freeze drying" in Encyclopedia of Pharmaceutical Technology, J. Swarbrick, ed. (New York, Informa Healthcare USA, 2007).

*This article is based on a presentation given at the 7th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP World Meeting) in Malta 2010.

Citation: When referring to this article, please cite it as "H. de Waard, N. Grasmeijer, W.L.J. Hinrichs, T. De Beer, H.W. Frijlink, "Controlled Crystallization During Freeze-Drying," Pharmaceutical Technology 35 (8) 58-62(2011)."


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
22%
To all process for new products only
12%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here